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Abstract: The objective of the current study was to estimate health risk indexes caused by the
inhalation of particulate matter (PM) by adult males and children using data sampled in three
European cities (Athens, Kuopio, Lisbon). Accordingly, the cancer risk (CR) and the hazard quotient
(HQ) were estimated from particle-bound metal concentrations whilst the epidemiology-based excess
risk (ER), the attributable fraction (AF), and the mortality cases were obtained due to exposure
to PM10 and PM2.5. CR and HQ were estimated using two methodologies: the first methodology
incorporated the particle-bound metal concentrations (As, Cd, Co, Cr, Mn, Ni, Pb) whereas the
second methodology used the deposited dose rate of particle-bound metals in the respiratory tract.
The indoor concentration accounts for 70% infiltration from outdoor air for the time activity periods
allocated to indoor environments. HQ was lower than 1 and the cumulative CR was lower than the
acceptable level (10−4), although individual CR for some metals exceeded the acceptable limit (10−6).
In a lifetime the estimated number of attributable cancer cases was 74, 0.107, and 217 in Athens,
Kuopio, and Lisbon, respectively. Excess risk-based mortality estimates (due to outdoor pollution) for
fine particles were 3930, 44.1, and 2820 attributable deaths in Athens, Kuopio, and Lisbon, respectively.
Keywords: particulate matter; health risks; dose; respiratory tract; metals; cancer risk; mortality
1. Introduction
Air pollution can cause respiratory and cardiovascular diseases [1–6] such as bronchitis, cardiac
arrhythmia, lung inflammation, lung fibrosis, deep vein thrombosis, and lung cancer [7–10]. Particulate
matter (PM) and other pollutants such as O3 and NO2 are responsible for these adverse health effects.
The WHO project “Health Risk of Air Pollution in Europe” (HRAPIE) focuses on quantifying air
pollution caused health impacts [4]. Epidemiological methods have been proposed for air pollution
health risk assessment [4]. Recent application of these methods has shown substantial health effects
also in areas with low pollution levels [11]. In addition, Pope et al. [12] pointed out that the relation
of PM2.5 level and life expectancy is stronger during a low pollution period. Health impacts and
the associated risk of the exposed subjects are necessary to investigate as they involve everyday life
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exposure to ambient contaminants. Hoek et al. [5] suggest that additional research is required in order
to examine the health effects of air pollution on susceptible subjects (e.g., obese).
According to the World Health Organization [6] PM was responsible for 3 million premature
deaths globally in 2016. However, Héroux et al. [4] pointed out that mortality due to PM exposure
was reduced by 20% between 2000 and 2010. Pope et al. [12] asserted that a decrease of PM2.5 level by
10 µg/m3 increased life expectancy by 0.61 year. Furthermore, Hoek et al. [5] found little evidence
between long-term exposure to coarse particles and mortality, whereas, Romanazzi et al. [13] indicated
that exposure to coarse particles is associated with pro-inflammatory and cytoxic effects. Several
studies [13–18] estimated the effect of PM on human health as well as the associated impact from
the chemical composition [13–16,18,19]. Accordingly, metal components such as As, Cd, Co, Cr (VI),
and Ni were investigated due to their carcinogenic health risk. Rogula-Kozłowska et al. [20] pointed
out that the most hazardous components of PM are polycyclic aromatic hydrocarbons (PAH) and
metals. Bello et al. [21] suggested that the majority of metals are toxic and may cause significant health
effects such as several types of cancer. In addition, Carpenter and Bushkin-Bedient [22] proposed that
exposure to a carcinogen during childhood can lead to an elevated cancer risk in later life. Therefore,
investigation of metal concentrations, their impact on human health, and age of the exposed subject is
of major importance due to their carcinogenic and toxic effects.
It is well established that natural sources emit mainly coarse particles (>2.5 µm) while
anthropogenic sources emit particles mainly in the fine/ultrafine region (<2.5 µm) [23]. Common
anthropogenic sources that release heavy metals in the ambient air are emissions from vehicles,
industry, domestic emissions, and weathering of buildings [24]. In addition, the chemical composition
of PM varies from city to city and depends on many factors such as geography, season, climate,
and combustion sources [10]. It is therefore crucial to conduct a risk assessment analysis to estimate the
effect of PM on human health and in different environments to map the potential risk from exposure
to airborne particles.
The aim of the present study is to apply several available scientific approaches to characterize
health risks caused by population exposures to airborne particulate matter. Specifically, we (i)
calculate particle bound metal cancer risks and non-cancer toxicity hazard quotients; (ii) estimate the
resulting numbers of cancer cases by city; (iii) calculate epidemiology-based estimates of all-cause
cardiopulmonary and lung cancer mortalities; (iv) compare and discuss the estimates obtained from
the alternative approaches; and (v) estimate and discuss the differences in body-weight adjusted metal
dose rates between adults and children.The current work is a follow-up study of the work presented
by Chalvatzaki et al. [25].
2. Material and Methods
2.1. Study Areas and Field Measurements
A methodology for assessment of the health risk due to air pollution was applied in three selected
European cities: Athens metropolitan area (Greece), Kuopio (Finland), and Lisbon metropolitan
area (Portugal) with populations of 3,754,000, 117,000, and 2,811,000, respectively. Simulations were
performed for both adult males and children who were considered residents in the under study
sites where experimental data for PM concentrations and particle-bound metal concentrations were
adopted from the literature [25–28]. Health risk indexes were estimated using the data implemented
in Chalvatzaki et al. [25] to obtain the deposited dose to the human respiratory tract and the results
(deposited dose rate) from the application of the exposure dose model 2 (ExDoM2; [29]) are used as
input. The methodology was applied to two age groups: adult males and children. Model simulations
(using ExDoM2) for children were performed separately for a 5- and a 10-year old child and the
average deposited dose rate was used in subsequent calculations. The equations of International
Commission on Radiological Protection (ICRP) [30,31] were used by ExDoM2 for the calculation of
deposition fractions.
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Sippula et al. [28] performed field measurements in Kuopio during 2010 for 2–3 weeks sampling
in each season. Average values of PM were used by Chalvatzaki et al. [25] and hence in the current
study. In particular, Sippula et al. [28] used a Harvard high-volume cascade impactor (HVCI) for
collection of particles into different size categories (<0.2 µm, 0.2–1 µm, 1–2.5 µm, and 2.5–10 µm).
Almeida et al. [26,27] performed field measurements in Lisbon using a Berner Impactor (Hauke LPI
30/0.06/2) during 2001 for 3 days in each season (again average values were used). The Berner
Impactor (Hauke LPI 30/0.06/2) collected particles in different size categories (0.0625–0.125 µm,
0.125–0.25 µm, 0.25–0.5 µm, 0.5–1 µm, 1.0–2.0 µm, 2.0–4.0 µm, 4.0–8.0 µm, 8.0–16.0 µm). The values
of the range (8.0–16.0 µm) were not used by Chalvatzaki et al. [25] and hence in the current study.
Finally, field measurements in Athens were performed from November 2014 to May 2015 using a low
pressure Berner cascade impactor which collects particles in different size categories (0.0255–0.062 µm,
0.062–0.11 µm, 0.11–0.173 µm, 0.173–0.262 µm, 0.262–0.46 µm, 0.46–0.89 µm, 0.89–1.77 µm, 1.77–3.4 µm,
3.4–6.8 µm, 6.8–13.35 µm, and >13.35 µm). Herein, the values from stages 6.8–13.35 µm and >13.35 µm
were not used (as well as in Chalvatzaki et al. [25]). Detailed description of the field measurements
in the study areas can be found in Chalvatzaki et al. [25] for Athens, in Sippula et al. [28] for Kuopio,
and in Almeida et al. [26,27] for Lisbon.
The present study used data from different periods for each city and hence no comparison between
the three cities was performed but our study aims to apply several available scientific approaches to
estimate health risks caused by exposure to particulate matter in several residential areas.
2.2. Health Risk Assessment Methodology for Particle-Bound Metals
The present study implements a methodology which is based on the risk assessment guidance
provided by the US EPA [32,33]. Accordingly, non-carcinogenic health risks are evaluated by the
hazard quotient (HQ) whereas the carcinogenic health risks are evaluated by the cancer risk (CR).
The hazard quotient is given as [32,33]:
HQ = CDI/RFD (1)
where CDI is the chronic daily intake (mg/kg/day) and RFD is the reference dose (mg/kg/day).
An HQ < 1 indicates no significant (acceptable) risk, and HQ > 1 suggests that the non-carcinogenic
effect is likely to appear [32,33] whilst a high chronic risk is denoted for HQ > 10 [34,35]. It should
be noted that the value of 10 is very high for ambient areas and is used for electronic-waste recycling
sites [34,35]. Two methodologies were used to estimate the daily intake. The US EPA [32,33] based
Methodology 1 incorporatesthe concentration of particle-bound metals and the inhalation rate to
obtain chronic daily intake (CDI, mg/kg) as shown in Equation (2). The second methodology uses the
deposited dose rate of particle-bound metals in the human respiratory tract that was first estimated
from the application [25] of a dosimetry model (ExDoM2; [29]) and then Equation (3) used as given by
Lyu et al. [15].
CDI =
Ca × IR× ET × EF× ED
BW × AT (2)
CDI =
(
DF× 10−6
)
× ET × EF× ED
BW × AT = (Ca × IR× DE)×
ET × EF× ED
BW × AT (3)
where Ca is the contaminant concentration (mg/m3), IR is the inhalation rate (m3/h), ET is the
exposure time (h/day), EF is the exposure frequency (days/year), ED is the exposure duration (years),
BW is the body weight (kg) of the exposed subject, AT is the averaging time (days), and DF is the
deposition flux or the deposited dose rate (ng/h) of the particle-bound metal in the human respiratory
tract. Equation (3) demonstrates that DF is obtained as the product of the contaminant concentration,
the inhalation rate, and the deposition fraction (DE) of the particle-bound metal in the respiratory
tract. Therefore, the two equations differ only in the use or not of DE. This implies that for cases
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where DE ≈ 1the two methodologies give similar results whereas for cases where DE < 1 the second
methodology provides results lower than that of the first methodology.
The advantage of using the deposited dose rate in the second methodology is that it takes
into account the deposition of particles in the human respiratory tract. As Rissler et al. [36]
found, the probability of particle deposition in the human respiratory tract is essential for its
toxic effects. Furthermore, the authors highlighted the variability of deposition between different
subjects (adults/children) therefore it is important to examine the impact of particle deposition in the
calculations. As our results suggest, the second methodology results in lower estimates because it
takes into account the mechanisms of particle deposition. The main mechanisms of particle deposition
are: impaction, sedimentation, and diffusion. Brown [37] proposed that particle deposition in the
respiratory tract is minimal in the range 0.1–1.0 µm because particles in this size range are small for
sedimentation/impaction and large for diffusion.
Reference values for the inhalation rate for adult males and children (average values of 5 and 10
year olds) were adopted according to ICRP [30]. For example, IR for adult males for light exercise,
sitting (rest) and sleep was set equal to 1.5, 0.54, and 0.45 m3/h, respectively [30]. Average IR was
implemented in Equation (2) according to the daily activity pattern which was used in Chalvatzaki
et al. [25]. Likewise, an average value was adopted for Ca. The indoor concentration was considered
to be 70% of the outdoor air (due to infiltration) for the time activity periods allocated to indoor
environments. The exposure time (ET) and exposure frequency (EF) were set equal to 24 h/day and
350 days/year respectively whilst the exposure duration (ED) was considered equal to 24 years for
adults and 6 years for children based on the US EPA [38]. Body weight (BW) was considered to be
73 kg for adults and 25.5 kg (average values of 5 and 10 year old children) for children [39]. Moreover,
according to the US EPA [38] the averaging time (AT) can be considered equal to 8760 days for adults
and 2190 days for children (ED × 365 days/year) for non-carcinogens while for carcinogens it can be
considered equal to 25,550 days (70 years × 365 days/year) for both adults and children.
The reference dose (RFD) is given as [38]:
RFD = RFC× (IRd/BW) (4)
where IRd (m3/d) is the daily inhalation rate estimated based on ICRP [30] and the daily activity
pattern which was used in Chalvatzaki et al. [25] while RFC (mg/m3) corresponds to a reference
concentration and is provided by US EPA [40]. Specifically, RFC is equal to 1.5 × 10−5, 1.0 × 10−5,
6.0 × 10−6, 1.0 × 10−4, 5.0 × 10−5, 2.0 × 10−5, 2.0 × 10−4 mg/m3 for As, Cd, Co, Cr (VI), Mn, Ni,
and Pb respectively [40].
The cancer risk (CR) represents the probability for an individual developing cancer and was
estimated by [32,33]:
CR = CDI × CSF (5)
where CSF is the cancer slope factor (mg/kg day)−1. The US EPA [38] considers values of CR < 10−6
acceptable; however, the cumulative CR for all potential carcinogenic contaminants must preserve
values <10−4 [13,41,42].
Finally, the cancer slope factor (CSF ) is estimated as [38]:
CSF = IUR×
(
BW
IRd
)
× 103 (6)
where IUR (µg/m3)−1 is the inhalation unit risk and is provided by US EPA [43]. Particularly, IUR is
equal to 4.3 × 10−3, 1.8 × 10−3, 9 × 10−3, 1.2 × 10−2, 2.6 × 10−4 (µg/m3)−1 for As, Cd, Co, Cr (VI),
and Ni, respectively [43].
We estimated the cancer incidences (number of new cancer cases) (I) per lifetime (70 years) in the
three cities based on the CR as followed:
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I = N × CR (7)
where I is the cancer incidence (cases), N is the number of people in the target city, and CR is the cancer
risk probability estimated in this work.
2.3. Health Risk Assessment Methodology for PM10 and PM2.5
The relative risk (RR) for all-cause mortality associated with short-term exposure to PM10 was
calculated using the equation provided by Ostro [44]. The relative risk is the probability of health
effects (e.g., all-cause mortality, lung cancer mortality) occurring in a population exposed to a level
of air pollution higher than that considered as background without any anthropogenic pollution
(10 µg/m3 for PM10; [44]).
The relative risk (RR) for all ages due to all-cause mortality was estimated by [44]:
RR = exp[β(X− X0)] (8)
where X is the annual mean concentration of PM10 (µg/m3), X0 is the baseline concentration of
PM10 (10 µg/m3), and β is the coefficient of the risk function (0.0008; 95% confidence interval (CI):
0.0006–0.0010).
In addition, the relative risk for cardiopulmonary and lung cancer mortality (age >30 years old)
associated with long-term exposure to PM2.5 was calculated by [44]:
RR = [(X+ 1)/(X0 + 1)]
β (9)
where X is the annual mean concentration of PM2.5 (µg/m3), X0 is the baseline concentration of PM2.5
(3 µg/m3), and β is the coefficient of the risk function. The coefficient β is equal to 0.15515 (95% CI:
0.0562–0.2541) for cardiopulmonary mortality while for lung cancer mortality β is equal to 0.23218
(95% CI: 0.08563–0.37873).
The functions of Ostro [44] were adopted because: (1) they are particularly handy for numerical
applications, (2) the more recent developments especially in the Intergrated Exposure Response (IER)
function [45,46] and subsequent GEMM [47] reflect also substantial uncertainties, (3) only the Burnett et
al. [45] version (of the IER functions) has been published at a level that can readily be reapplied; comparison
of Ostro [44] with it shows that Ostro’s function for cardiopulmonary mortality (the most significant
mortality component) is roughly double, and (4) in the next iteration of IER the threshold (TMERD) was
brought down from 5–6 µg m−3 to 2–3 µg m−3, which is very close to the value applied by Ostro.
Once the relative risk (RR) is determined, the attributable fraction (AF) is estimated as [44]:
AF = (RR− 1)/RR (10)
The AF estimates the proportion of deaths from a disease (e.g., lung cancer) which could be
avoided if PM levels were reduced to 10 µg/m3 and 3 µg/m3 for PM10 and PM2.5, respectively [44].
Equations (8)–(10) estimate the RR and AF due to outdoor air pollution. The RR estimates are presented
as excess risk (ER = RR− 1) later on.
The attributable deaths (AI) were calculated using AF and background mortality (I) in the target
cities [48]:
AI = AF× I (11)
where AI is the number of deaths attributable to exposure and I is the total number of deaths in the
target population. Age-adjusted estimates calculated from annual national mortality data for 2015
were obtained from the WHO [49]. The country level estimates for the selected cities were calculated
by multiplying country levels deaths with the fractions of the country’s population living in the under
study city.
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3. Results and Discussion
3.1. Ambient Concentration and Deposited Dose Rate of Particle-Bound Metals
Tables 1 and 2 list the PM concentrations and particle-bound metal concentrations respectively for
each city. In addition, Tables 3 and 4 give the deposited dose rate of the particle-bound metals for adult
males and children respectively. The values of Tables 1 and 2 represent the measured concentrations
by experimental techniques in the under study sites [25–28] whereas the values in Tables 3 and 4
correspond to the modeled results obtained from the use of the dosimetry model ExDoM2 for adult
males [25] and children respectively. The values suggest that the deposited dose rates were 1.7–1.9
times higher per body weight in children.
Table 1. Mass concentration (µg/m3) of outdoor particulate matter (PM) in each city [25–28].
Athens Kuopio Lisbon
PM1.77 PM6.8 PM2.5 PM10 PM2 PM8
11.1 19.6 6.2 10.3 21.3 36.6
Table 2. Outdoor concentration (ng/m3) of particle-bound metals in each city [25–28].
Athens (PM6.8) Kuopio (PM10) Lisbon (PM8)
As 2.87 0.21 0.46
Cd - 0.07 -
Co 3.53 * 0.09 0.67
Cr 2.39 0.34 23.75
Mn 14.96 4.19 -
Ni 7.47 * 7.12 -
Pb 6.01 1.56 -
* unpublished data from the same sampling period.
Table 3. Deposited dose rate (ng/h) of particle-bound metals in the human respiratory tract for adult
males [25].
Athens Kuopio Lisbon
Average min–max Average min–max Average min–max
As 1.45 0.50–2.60 0.07 0.02–0.13 0.18 0.06–0.32
Cd - - 0.02 0.01–0.04 - -
Co 1.64 0.55–2.97 0.06 0.02–0.11 0.40 0.12–0.75
Cr 1.03 0.31–1.89 0.21 0.07–0.37 10.60 3.29–19.46
Mn 7.46 2.60–13.38 2.36 0.81–4.22 - -
Ni 3.31 1.12–5.97 1.96 0.55–3.68 - -
Pb 1.70 0.61–3.02 0.64 0.20–1.16 - -
Table 4. Deposited dose rate (ng/h) of particle-bound metals in the human respiratory tract for children
(average values of 5- and 10-year old children).
Athens Kuopio Lisbon
Average min–max Average min–max Average min–max
As 0.85 0.31–1.49 0.04 0.01–0.08 0.11 0.04–0.19
Cd - - 0.02 0.01–0.03 - -
Co 0.98 0.35–1.73 0.04 0.01–0.06 0.25 0.08–0.44
Cr 0.64 0.21–1.15 0.12 0.05–0.21 6.53 2.19–11.72
Mn 4.35 1.62–7.64 1.42 0.51–2.49 - -
Ni 1.97 0.71–3.48 1.33 0.38–2.46 - -
Pb 1.04 0.39–1.82 0.40 0.13–0.71 - -
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PM concentrations were the highest in Lisbon (36.6 µg/m3 and 21.3 µg/m3) followed by Athens
(19.6 µg/m3 and 11.1 µg/m3), and Kuopio (10.3 µg/m3 and 6.2 µg/m3) (Table 1). The mass percentage
for fine particles (PM2.5 for Kuopio; PM2.0 for Lisbon, and PM1.77 for Athens) is higher than for coarse
particles (PM2.5–10 for Kuopio; PM2.0–8.0 for Lisbon, and PM1.77–6.8 for Athens) for all cities. In particular,
the mass percentage for fine particles is equal to 56%, 58%, and 60% in Athens, Lisbon, and Kuopio,
respectively. Bigger cities are expected to preserve higher ambient PM concentrations compared to
smaller cities due to increased anthropogenic activities. Additionally, Querol et al [50] emphasized
that variations in PM concentrations may be observed between countries (e.g., Mediterranean and
Scandinavian countries) with different climatologic and geographical patterns. Likewise, International
Agency of Research on Cancer (IARC) [51] emphasized that PM10 concentrations in southern Europe
are higher than that of north-western Europe. Regarding the concentrations of particle-bound metals
higher concentrations in Athens were obtained for Mn (14.96 ng/m3) followed by Ni (7.47 ng/m3)
among the measured metals. Similarly, Ni (7.12 ng/m3) and Mn (4.19 ng/m3) preserved elevated
concentrations in Kuopio whilst a substantially higher concentration of Cr (23.75 ng/m3) was measured
in Lisbon compared to the rest of the particle-bound metals that were measured in this site. Herein,
the average deposited dose rates given (Tables 3 and 4) were used for the calculation of the Hazard
Quotient and Cancer Risk. Originally, the deposited dose rates were estimated based on an hourly
variation due to the different microenvironment (outdoor, indoor) and physical activity of the exposed
subject (sleep, sitting awake, light activity) according to the daily activity pattern which was used
by Chalvatzaki et al [25] in the ExDoM2. The same daily activity pattern was used for adult males
and children to examine the effect of age on the deposited dose rate. Accordingly, it was observed
that the deposited dose rate for adult males is higher compared to the deposited dose obtained for
children, a characteristic that is associated with the higher inhalation rate of adults. In addition,
the maximum rate corresponds to the period when the subject (both adults and children) was exposed
to the outdoor environment doing light exercise whereas the minimum rate was obtained when the
subject was sleeping indoors. These results were associated with the lower concentration in the indoor
environment (absence of indoor sources) and the lower inhalation rate during sleep.
3.2. Hazard Quotients and Cancer Risks
3.2.1. Hazard Quotients
The hazard quotient (for non-carcinogenic health risks) obtained for the measured seven metals
in the three cities were estimated for adults and children respectively (Tables 5 and 6). Accordingly,
the cumulative HQ (or hazard index) was lower than the limit of 1 in all examined cases except for
Athens when the first methodology was used. Thus, the present results indicate no significant risk
from inhalation exposure to these metal compounds although a higher risk exists for Athens if the first
methodology is taken into account.
Table 5. Hazard quotient for adult males estimated from both methodologies for each metal and city.
City Metal Methodology 1(US EPA)
Methodology 2
(Lyu et al. [15])
Athens As 1.47 × 10−1 9.32 × 10−2
Cd - -
Co 4.51 × 10−1 2.64 × 10−1
Cr 1.83 × 10−2 9.92 × 10−3
Mn 2.30 × 10−1 1.44 × 10−1
Ni 2.87 × 10−1 1.60 × 10−1
Pb 2.31 × 10−2 8.20 × 10−3
Cumulative 1.16 6.79 × 10−1
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Table 5. Cont.
City Metal Methodology 1(US EPA)
Methodology 2
(Lyu et al. [15])
Kuopio As 1.06 × 10−2 4.52 × 10−3
Cd 5.06 × 10−3 2.11 × 10−3
Co 1.18 × 10−2 9.87 × 10−3
Cr 2.59 × 10−3 1.99 × 10−3
Mn 6.43 × 10−2 4.55 × 10−2
Ni 2.73 × 10−1 9.47 × 10−2
Pb 5.99 × 10−3 3.07 × 10−3
Cumulative 3.73 × 10−1 1.62 × 10−1
Lisbon As 2.34 × 10−2 1.13 × 10−2
Cd - -
Co 8.55 × 10−2 6.50 × 10−2
Cr 1.82 × 10−1 1.02 × 10−1
Mn - -
Ni - -
Pb - -
Cumulative 2.91 × 10−1 1.79 × 10−1
Table 6. Hazard quotient for children estimated from both methodologies for each metal and city.
City Metal Methodology 1(US EPA)
Methodology 2
(Lyu et al. [15])
Athens As 1.47 × 10−1 9.42 × 10−2
Cd - -
Co 4.51 × 10−1 2.72 × 10−1
Cr 1.83 × 10−2 1.07 × 10−2
Mn 2.30 × 10−1 1.45 × 10−1
Ni 2.87 × 10−1 1.64 × 10−1
Pb 2.31 × 10−2 8.64 × 10−3
Cumulative 1.16 6.95 × 10−1
Kuopio As 1.06 × 10−2 4.96 × 10−3
Cd 5.06 × 10−3 2.66 × 10−3
Co 1.18 × 10−2 1.00 × 10−2
Cr 2.59 × 10−3 2.05 × 10−3
Mn 6.43 × 10−2 4.72 × 10−2
Ni 2.73 × 10−1 1.10 × 10−1
Pb 5.99 × 10−3 3.30 × 10−3
Cumulative 3.73 × 10−1 1.81 × 10−1
Lisbon As 2.34 × 10−2 1.17 × 10−2
Cd - -
Co 8.55 × 10−2 6.83 × 10−2
Cr 1.82 × 10−1 1.09 × 10−1
Mn - -
Ni - -
Pb - -
Cumulative 2.91 × 10−1 1.89 × 10−1
Likewise, HQ for each metal was lower than the acceptable level (HQ < 1) for all cases involved
and again no significant toxic effect is expected. Megido et al. [52] reports values of HQ equal to 0.063
and 0.027 for As and Co respectively which is close to the ones presented in this study for As (0.023
methodology 1; 0.011 methodology 2) and Co (0.086 methodology 1; 0.065 methodology 2).
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Methodology 1 provides slightly higher estimates (1.2–2.9-fold, mean 1.8 fold) compared to
the second methodology. This observation induces a significant implication on the use of each
methodology. Intrinsically, the second methodology includes the use of the deposited dose rate
through the deposition fraction, which preserves values lower than 1, in the calculation of CDI.
On the other hand, the first methodology considers only the ambient concentration of particles for the
estimation of CDI. Therefore, the second methodology always results in lower estimates compared to
the first methodology.
Additionally, using the first methodology to estimate the hazard quotient produced equal
estimates for adults and children. The same observation is reported in Wang et al. [53] regarding
inhalation exposure of heavy metals in fine particles. On the contrary, using the second methodology
to obtain HQ, higher estimates corresponded to children compared to adults. Again, this characteristic
is attributed to the deposition fraction that was considered in the second methodology. Several
studies [36,54,55] asserted that the deposition fraction in children is higher than that in adult males,
which in turn results in higher HQ (although the deposited dose rate is higher in adult males due to
the higher inhalation rate). Lastly, cumulative HQ is expected to preserve higher estimates if exposure
to metals via ingestion and dermal contact is considered.
3.2.2. Cancer Risks
The cancer risk (via inhalation) estimated for each metal in the three under study cities using
both methodologies for adult males and children respectively is shown Figure 1a,b. Again, the results
indicate that the first methodology provides higher estimates. Based on the US EPA [38] the exposure
duration and averaging time was set equal to 24 and 70 years for adults, whilst, the corresponding
values for children were 6 and 70 years [38]. Therefore, CR for children was lower due to the lower
exposure duration. A similar finding is reported in Bello et al. [21] as well as in Wang et al. [53]
regarding CR of inhaled PM2.5-bound trace metals. However, both studies found that CR for children
was higher than that for adults through ingestion exposure.
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Overall, lower estimates of cancer risk (for both methodologies) were obtained for Kuopio due to
the lower metal concentrations (Table 2). However, differences apply within each city and the cancer
risk for individual metal compounds ranges from values higher than the acceptable limit to values
lower than 10−6.
Cancer risk levels for Cd and Ni obtained for all cities were lower than 10−6, suggesting low or
acceptable risks. On the other hand, a CR > 10−6 was obtained for As in Athens, whilst, the cancer risk
for Co and Cr was higher than the acceptable level in Athens and Lisbon. Note that the cancer risk for
Cr in Kuopio using the first methodology is slightly higher than the acceptable limit (1.1 × 10−6) and
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that there are no available data (inhalation unit risk) for total or trivalent Cr. Therefore, the inhalation
unit risk of hexavalent Cr was used although the total Cr was measured in these cities. The cancer risk
of Cr in Lisbon (7.50× 10−5 methodology 1; 4.21× 10−5 methodology 2) was at a similar level with the
cancer risk (3.7 × 10−5) obtained in an urban area in the center of Porto (Portugal) by Pinto et al. [16],
where, the authors also used the inhalation unit risk of hexavalent Cr while the total concentration
of Cr was measured in their study. Additionally, Megido et al. [52] reports a cancer risk for Co via
inhalation at 1.1 × 10−6 in an industrial suburban station in Asturias (Spain).
Using population data from the target cities we calculated the estimates of cancer cases, showing
a total of approximately 74 cancers in a lifetime in Athens, 0.11 cancers in Kuopio, and 217 cancers in
Lisbon (Table 7). Cancer case estimates were dominated by Cr and Co.
Table 7. Cancer risk based estimates of cases per lifetime in the three cities.
Cancer Cases per Lifetime (70 Years)
Methodology 1 (US EPA) Methodology 2 (Lyu et al. [15])
Athens Kuopio Lisbon Athens Kuopio Lisbon
As 12.2 0.020 1.5 7.7 0.008 0.7
Cd - 0.003 - - 0.001 -
Co 31.3 0.018 4.4 18.4 0.015 3.4
Cr 28.3 0.090 210.8 15.3 0.069 118.3
Ni 1.9 0.041 - 1.1 0.014 -
Cumulative 73.7 0.172 216.7 42.5 0.107 122.4
At the end, the cumulative cancer risk (both adults and children) in all three cities and for
both methodologies was lower than the acceptable limit 10−4 [38,41] as shown in Figure 1. Herein,
the cancer risk was estimated considering only inhalation, whilst, the exposure to metals occurs also
via ingestion and dermal contact. Therefore, the cumulative cancer risk is expected to be higher if
ingestion and dermal contact are considered [13]. This observation is reported in Megido et al. [52]
where the cumulative cancer risk via ingestion was higher than 10−4 at an industrial suburban station
in Asturias (Spain).
3.3. Excess Risk and Attributable Mortality
Excess risks and the attributable fractions for all-cause mortality were estimated for each city using
PM10 data for Kuopio, PM8 for Lisbon, and PM6.8 for Athens (Table 8). Accordingly, the excess risks
were estimated at 0.77%, 0.02%, and 2.2% for Athens, Kuopio, and Lisbon respectively. These results
demonstrate that a higher excess risk was obtained for Lisbon and suggests that an individual in
a group exposed to the corresponding PM concentration in Lisbon is more likely to present a health
effect (all-cause mortality) than an individual in a group that is exposed to a background concentration
of 10 µg/m3 (PM10) by 2.2%. Similarly, the lower excess risk that corresponds to Kuopio (0.02%)
indicates a safer ambient PM10 concentration for a recipient under the conditions measured in this site.
Regarding the results for the attributable fraction, Table 8 indicates that 0.77%, 0.02%, and 2.11% of
all-cause mortality could be avoided in Athens, Kuopio, and Lisbon respectively if PM10 concentration
was reduced to 10 µg/m3. Again, higher AF was obtained for Lisbon which represents a higher risk
for this case study. A similar finding was published in the city of Valladolid in Spain by Cardaba
Arranz et al. [56], where, the authors found that 2% of all-cause mortality was attributed to particulate
matter pollution.
Furthermore, ER and AF for cardiopulmonary and lung cancer mortality due to long-term
exposure to PM2.5 (PM2.0 for Lisbon and PM1.77 for Athens) are listed in Table 8. The excess risk for
cardiopulmonary mortality was found equal to 19%, 9.5%, and 31% for Athens, Kuopio, and Lisbon
respectively whilst the attributable fraction suggests that cardiopulmonary mortality can be prevented
by 15.8%, 8.7%, and 23.4% in Athens, Kuopio, and Lisbon respectively if fine particle mass concentration
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preserves levels close to the background concentration of 3 µg/m3. Pokorski [57] who conducted
a study during the period 2006–2011 found that percentages of 15% and 22% for cardiopulmonary
mortality could be prevented in Lublin and Katowice respectively. Likewise, for lung cancer mortality
ER in Athens, Kuopio, and Lisbon was found equal to 29%, 15%, and 49% respectively with % AF
being equal to 22.7, 12.8, and 32.9 for Athens, Kuopio, and Lisbon, respectively (Table 8). Similar results
are published in Pokorski [57] where the authors found that lung cancer mortality can be prevented by
23% and 32% in Lublin and Katowice respectively, whilst, Cardaba Arranz et al. [56] found that 26% of
cardiopulmonary mortality and 36% of lung cancer mortality can be prevented in Valladolid if the
ambient concentration was equal to 3 µg/m3. In addition, Evans et al. [58] proposed that the global
fraction of mortality attributed to PM2.5 was 12.1% for cardiopulmonary disease and 16.8% for lung
cancer. The authors also pointed out that the eastern Mediterranean and western Pacific regions had
a greater AF of mortality associated with PM2.5 in comparison with African sub regions.
Furthermore, Table 8 indicates that the sum of deaths due to cardiopulmonary mortality and lung
cancer are 3930, 44, and 2820 for Athens, Kuopio, and Lisbon respectively. The annual total mortality
rate was approximately 1% in all the cities, ranging from the minimum value of 0.92% for Kuopio
to maximum of 1.2% in Lisbon. Herein, the estimated deaths due to air pollution in Athens, Kuopio,
and Lisbon represent ca. 0.1% of the total mortality in Athens and Lisbon and 0.04% in Kuopio.
Table 8. Percentages (%) of the excess risks (ER) and attributable fractions (AF) along with the
number of attributable deaths for (a) all-cause mortality associated with short-term exposure to PM10,
(b) cardiopulmonary mortality and (c) lung cancer mortality associated with long term exposure to
PM2.5 in each city. The corresponding confidence intervals (CI) are given in brackets.
Athens Kuopio Lisbon
(a) All-cause mortality (PM10)
ER (95% CI) 0.77 (0.58–0.96) 0.02 (0.02–0.03) 2.2 (1.6–2.7)
AF (95% CI) 0.77 (0.57–0.96) 0.02 (0.02–0.03) 2.1 (1.58–2.62)
Deaths (95% CI) 320 (236–398) 0.2 (0.2–0.3) 730 (546–905)
(b) Cardiopulmonary mortality (PM2.5)
ER (95% CI) 19 (6.4–33) 9.5 (3.4–16) 31 (10–55)
AF (95% CI) 15.8 (6.0–24.5) 8.7 (3.2–13.9) 23.4 (9.2–35.4)
Deaths (95% CI) 3450 (1311–5353) 38 (14–61) 2450 (962–3702)
(c) Lung cancer mortality (PM2.5)
ER (95% CI) 29 (9.9–52) 15 (5.2–25) 49 (16–92)
AF (95% CI) 22.7 (9.0–34.2) 12.8 (4.9–20.0) 32.9 (13.7–47.8)
Deaths (95% CI) 480 (190–721) 6.1 (2.3–9.5) 370 (155–540)
Sum of deaths (b+c) 3930 44.1 2820
In this study we applied different methods for risk characterization: cancer risk (CR), hazard
quotient (HQ), hazard index, attributable all-cause mortality, and cause specific mortality. Xiong et
al. [59] discussed the strengths and weaknesses of these methods, pointing out that the hazard
index and hazard quotients are merely indicators and are suitable for identifying a potential risk;
they cannot be used for true quantification of the risks. Cancer slope-based risk estimates represent
the probability of an individual developing cancer in a 70-year lifetime at a given chronic average
daily intake level. While the risk estimate is quantitative and risks from multiple exposures can be
summed up (additivity), the definition built on lifetime risk makes it somewhat difficult to interpret
the risk magnitude in a normal decision making context. It is easier to interpret epidemiological risk
assessment-based annual number of cases. Xiong et al. [59] pointed out that the numbers of cases are
useful for risk comparisons, estimation of economic impacts, and setting priorities.
In our work the cancer slope factor-based estimates of cancer cases attributable to heavy metals
were small. Excess risk-based estimates of deaths are substantially larger for all three mortality models.
It is clear that the component specific cancer risk model lacks polycyclic aromatic hydrocarbons known
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to be carcinogenic, as well as potentially carcinogenic components such as black carbon and secondary
organics. It is important to develop the dose-based health risk modeling towards better comparability
with epidemiological RR-based risk estimates. This would allow for taking advantage of the refined
respiratory tract dose model features.
Comparing PM10-based all-cause mortality estimates with the PM2.5-based cause-specific
mortalities the former produces smaller number of deaths for all cities. The PM2.5-based cause-specific
mortality models for cardiopulmonary and lung cancer mortalities therefore totally dominate the
overall effects. Only in Lisbon the all-cause mortality exceeded the lung cancer mortality estimate.
It should be noted that the relative risk-based mortality estimates included baseline levels (10 µg/m3
for PM10 and 3 µg/m3 for PM2.5). Any possible health or mortality effects under these were not
accounted for.
The PM2.5-based mortality estimates, cardiopulmonary and lung cancer mortality are
mutually exclusive and can therefore be summed together. The PM10-based all-cause mortality
in principle contains the former ones and should not be added to the PM2.5 estimates in order to
avoid double-counting.
Cancer slope-based cancer risks potentially partly overlap with the mortality risks. However,
the magnitude of the former ones is substantially smaller and thus any practical implications of
potential double counting can be ignored. The cancer slope and hazard quotient-based risk estimates
account for the respiratory tract deposition of particles. This methodology is very interesting and
promising for future development. However at least in the current work it seems that merely
focusing on PM2.5-attributed cause-specific mortality captures the magnitude of health risks in the
adult populations.
In the case of the children, mortality is a substantially less relevant endpoint. It would be
interesting to develop methods to study effects on e.g., respiratory infections, school absenteeism,
and academic performance.
4. Conclusions
Human health risks associated with exposure to particle-bound metals (cancer risk and hazard
quotient) and particle mass concentrations (PM10 and PM2.5) (excess risks and attributable deaths) were
estimated in the current study. Ambient air quality data was obtained, human time-activity weighted
exposures calculated, and respiratory tract doses were estimated in three selected European cities
(Athens, Kuopio, and Lisbon). Due to the different sampling periods and locations no comparison
between the three cities was performed but the data were used in order to retrieve the corresponding
estimates for the health indexes and discuss their implications.
In particular, we applied several risk models and compared their results to evaluate
non-carcinogenic, cancer, and mortality risks. It was found that the non-carcinogenic health risks
(Methodology 2) are greater in children because the deposition fraction of children is higher than the
deposition fraction of adults. On the other hand, the carcinogenic health risks (for both methodologies)
were found to be higher for adults due to the higher ratio of exposure duration to averaging time.
The hazard quotient that represents the non-carcinogenic effects due to the inhalation of
particle-bound metals was lower than the acceptable level (<1). Hence no significant risk is expected
for all the cases investigated. In addition, the cumulative cancer risk was lower than the acceptable
level (10−4). However, the cancer risk for some metals was higher than the acceptable level (10−4) thus
a health risk is expected from exposure to these metals. Both the excess risk and attributable fraction
(for PM10 and PM2.5) were higher in Lisbon compared to Athens and Kuopio due to higher ambient
concentrations measured in this city. In addition, the results have shown that the first methodology
provides higher CRand HQ compared to the second methodology for all cases investigated.
The epidemiology-based lung cancer and cardiopulmonary mortality estimates were higher
than the annual total cancers estimated from the toxicological life time cancer risks. In Athens and
Lisbon the excess mortality rate caused by air pollution was approximately 0.1%, and in Kuopio 0.04%.
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The background mortality level was 0.92% in Kuopio, 1.1% in Athens, and 1.2% in Lisbon. There are
specific benefits in respiratory tract dose modeling, but at the moment it seems that the overall health
impact is best captured—or at least dominated—by using PM2.5 excess risk-based mortality models.
Although, PM concentrations for the cities under study do not exceed air quality standards the
present study highlights that the health impacts from exposure to air pollution are still an important
issue. Finally, implementation of several available scientific approaches to estimate health risks caused
by exposure to airborne particulate matter is an important step for air pollution control and for
mitigation of urban air pollution.
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